These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12406801)

  • 21. Hepatitis B vaccine uptake among injecting drug users in England 1998 to 2004: is the prison vaccination programme driving recent improvements?
    Hope VD; Ncube F; Hickman M; Judd A; Parry JV
    J Viral Hepat; 2007 Sep; 14(9):653-60. PubMed ID: 17697018
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Should Europe have a universal hepatitis B vaccination programme?
    Van Damme P; Leuridan E; Hendrickx G; Vorsters A; Theeten H; Leino T; Salminen M; Kuusi M
    BMJ; 2013 Jul; 347():f4057. PubMed ID: 23843546
    [No Abstract]   [Full Text] [Related]  

  • 23. Hepatitis B vaccination and injecting drug use: narrowing the efficacy-effectiveness gap.
    Maher L
    Int J Drug Policy; 2008 Dec; 19(6):425-8. PubMed ID: 18289840
    [No Abstract]   [Full Text] [Related]  

  • 24. [Difficult to motivate intravenous addicts for vaccination against hepatitis. The campaign in Blekinge was not successful: it reached only 10 percent of the group].
    Eitrem R
    Lakartidningen; 2003 Feb; 100(6):424-6. PubMed ID: 12607435
    [No Abstract]   [Full Text] [Related]  

  • 25. Adherence to hepatitis B virus vaccination at syringe exchange sites.
    Altice FL; Bruce RD; Walton MR; Buitrago MI
    J Urban Health; 2005 Mar; 82(1):151-61. PubMed ID: 15746385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Working at the sharp end. Interview by Leona Armstrong.
    Kirk W
    Nurs Times; 2002 Dec 10-16; 98(50):44-5. PubMed ID: 12518553
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatitis B vaccines: WHO position paper – July 2017.
    Wkly Epidemiol Rec; 2017 Jul; 92(27):369-92. PubMed ID: 28685564
    [No Abstract]   [Full Text] [Related]  

  • 28. Vaccine immunogenicity in injecting drug users.
    Schmidt M
    Lancet Infect Dis; 2009 Feb; 9(2):77-8. PubMed ID: 19179222
    [No Abstract]   [Full Text] [Related]  

  • 29. Outcome of a hepatitis B vaccination program for clients of a drug consumption facility.
    Scherbaum N; Timm J; Richter F; Bonnet U; Bombeck J; Lajos S; Specka M
    J Clin Virol; 2018 Sep; 106():28-32. PubMed ID: 30015286
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B vaccination coverage and risk factors associated with incomplete vaccination of children born to hepatitis B surface antigen-positive mothers, Denmark, 2006 to 2010.
    Kunoee A; Nielsen J; Cowan S
    Euro Surveill; 2016; 21(7):pii=30136. PubMed ID: 26923681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Screening for hepatitis B and vaccination of injecting drug users in NHS drug treatment services.
    Farrell M; Battersby M; Strang J
    Br J Addict; 1990 Dec; 85(12):1657-9. PubMed ID: 2149662
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reach of a hepatitis B vaccination programme among men who have sex with men.
    Baars JE; Boon BJ; Garretsen HF; van de Mheen D
    Eur J Public Health; 2011 Jun; 21(3):333-7. PubMed ID: 20813894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy.
    Elefsiniotis IS; Pantazis KD; Ketikoglou ID; Koutsounas SI; Tsianos EV
    Eur J Gastroenterol Hepatol; 2006 Nov; 18(11):1227-31. PubMed ID: 17033445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The necessity of education and hepatitis B vaccination for young people: A study of high risk behaviour for blood borne viruses in the United Kingdom.
    Sira J; Brown M; Ambegaokar S; Modin L; Kelly DA
    J Child Health Care; 2019 Sep; 23(3):437-445. PubMed ID: 30818996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program.
    Alanko Blomé M; Björkman P; Flamholc L; Jacobsson H; Widell A
    Vaccine; 2017 Jan; 35(1):84-90. PubMed ID: 27894721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of the media on vaccine uptake in British Columbia's grade 6 hepatitis B immunization program.
    Bigham M; Schiefele D; Dobson S
    Can Commun Dis Rep; 1999 May; 25(10):89-93; discussion 93-4. PubMed ID: 10349746
    [No Abstract]   [Full Text] [Related]  

  • 37. [A nested case control study for risk factors impacting hepatitis B vaccination in Hebei, China].
    Ma JC; Han CZ; Qi SX; Tian C; Li J; Zhao SJ; Zhang Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):201-4. PubMed ID: 19031703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age at presentation for infant immunization in Nigeria: implications for hepatitis B immunization.
    Sadoh AE; Eregie CO
    Public Health; 2008 Dec; 122(12):1318-20. PubMed ID: 18706664
    [No Abstract]   [Full Text] [Related]  

  • 39. Convenience is the key to hepatitis A and B vaccination uptake among young adult injection drug users.
    Campbell JV; Garfein RS; Thiede H; Hagan H; Ouellet LJ; Golub ET; Hudson SM; Ompad DC; Weinbaum C;
    Drug Alcohol Depend; 2007 Nov; 91 Suppl 1():S64-72. PubMed ID: 17276018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gender differences in hepatitis C seroprevalence and suboptimal vaccination and hepatology services uptake amongst substance misusers.
    Marufu M; Williams H; Hill SL; Tibble J; Verma S
    J Med Virol; 2012 Nov; 84(11):1737-43. PubMed ID: 22997076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.